Abstract
Prescribing for older people is complex particularly in the presence of multi-morbidity. Ensuring the appropriate balance of prescribed medicines requires a consideration of pharmacokinetic and pharmacodynamics parameters, a knowledge of the potential adverse effects as well as the potential for inappropriate prescribing. Adopting a systematic approach to ensure that patients receive the maximum benefit from their prescribed treatment is essential. While various approaches can be used, it is important that the approach undertaken is tailored to individual patient needs and what is achievable within the clinical practice setting.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
United Nations: World population ageing [online] New York: United Nations. Available at: http://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2013.pdf (2013). Accessed: 02.01.18.
World Health Organisation: The Global strategy and action plan on ageing and health Available from: http://who.int/ageing/global-strategy/en/ (2016). Accessed: 02.01.18.
Marengoni A, Angleman S, Melis R, Mangialasche F, Krap A, Garmen A, Meinow B, Fratiglioni L. Ageing with multimorbidity: a systematic review of the literature. 2011;10:430–9.
Bell SP, Saraf AA. Epidemiology of multimorbidity in older adults with cardiovascular disease. Clin Geriatr Med. 2016;32(2):215–26.
Field TS, Mazor KM, Briesacher B, Debellis KR, Gurwitz JH. Adverse drug events resulting from patient errors in older adults. J Am Geriatr Soc. 2007;55(2):271–6.
Corsonello A, Pedone C. Antonelli Incalzi Age-related pharmacokinetic and pharmacodynamics changes and related risk of adverse drug reactions. Curr Med Chem. 2010;17:571–84.
Mangoni A, Jackson S. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;29:927–8.
Dhillon S, Gill K. Clinical Pharmacokinetics. Clinical pharmacokinetics in the elderly. UK: Pharmaceutical Press; 2006. p. 1–44.
Ewing AB. Altered drug response in the elderly. In: Armour D, Cairns C, editors. Medicines in the elderly. London: Pharmaceutical Press; 2002. pp. 15–28.
Jackson SH. Pharmacodynamics in the elderly. J R Soc Med. 1994;87:5–7.
Payne PA, Avery AJ. Polypharmacy: one of the greatest prescribing challenges in general practice. Br J Gen Pract. 2011;61:83–4.
Hughes CM, Cooper JA, Ryan C. Going beyond the numbers- a call to redefine polypharmacy. Br J Clin Pharmacol 2014; 916.
The King’s Fund. Polypharmacy and medicines optimisation: making it safe and should. London. Available from: https://www.kingsfund.org.uk/publications/polypharmacy-and-medicines-optimisation (2013). Accessed: 02.01.18.
World Health Organization (WHO). WHO Draft Guidelines for Adverse Event Reporting and Learning Systems. Geneva: WHO, 2005.
Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc. 2003;78(12):1564–77.
O’Connor MN, Gallagher P, O’Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. 2012;29(6):437–52.
National Institute of Health and Care Excellence (NICE). Multimorbidity: Clinical Assessment and Management. Clinical Guideline NG56. Available from: https://www.nice.org.uk/guidance/ng56/resources.
Scottish Government Model of are Polypharmacy Working Group: Polypharmacy guidance. 2nd ed. Scotland. Available from: http://www.sehd.scot.nhs.uk/publications/DC20150415polypharmacy.pdf (2015). Accessed: 02.01.18.
Royal Pharmaceutical Society: Medicines optimisation: medicines optimisation: the evidence in practice. Available from: https://www.rpharms.com/Portals/0/RPS%20document%20library/Open%20access/Policy/helping-patients-make-the-most-of-their-medicines.pdf (2015). Accessed: 02.01.18.
Pazan F, Weiss C, Wehling M. FORTA. The FORTA (Fit For The Aged) List 2015: update of a validated clinical tool for improved pharmacotherapy in the elderly. Drugs Aging. 2016;33(6):447–9.
O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for p[potentially inappropriate prescribing in older people: version 2. Age Ageing 2014;0:1–6.
Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107(31–32):543–51.
Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM, Lewis IK, Landsman PB, Cohen HJ. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol. 1994;47(8):891–6.
Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63(8):725–31.
Hill-Taylor B, Walsh KA, Stewart S, Hayden J, Byrne S. Effectiveness of the STOPP/START (Screening Tool of Older Persons’ potentially inappropriate Prescriptions/ Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther. 2016;41:158–69.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Ryan, C., O’Dwyer, M. (2019). Pharmaceutical Care in the Aged. In: Alves da Costa, F., van Mil, J., Alvarez-Risco, A. (eds) The Pharmacist Guide to Implementing Pharmaceutical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-92576-9_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-92576-9_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92575-2
Online ISBN: 978-3-319-92576-9
eBook Packages: MedicineMedicine (R0)